Product development ideas are generated in numerous ways, including:
- regular cross functional meetings where all senior staff are encouraged to bring new ideas from their experience in the marketplace;
- networking with key opinion leaders, especially in our focus therapeutic areas, to identify and develop ideas; and
- employing talented veterinary scientists who extensively screen scientific papers looking for new technologies that might have an application in our marketplace.
In addition, our profile gives us exposure to human pharmaceutical and biotech companies that are developing technologies, usually for human medicine, but often with a veterinary application. We spread our development portfolio across novel entities, differentiated generics, generics and lifecycle management projects across multiple species.
Our formulation and development laboratories are located at our manufacturing sites which allows manufacturing and product development to work closely together to scale up to commercial production, which is a key expertise for in-house product development. After opportunities have been identified we have an evaluation phase where we assess opportunities and ideas to determine whether we can technically manufacture the product and whether it is commercially viable to do so. Once a product has been classed as suitable for development it will be allocated to an internal development team who will be responsible for taking the product all the way through feasibility, research and development to regulatory submission. Once all the studies are concluded, if the product reaches the required safety, efficacy and stable chemical criteria, regulatory dossiers are prepared for registration and filing with the relevant regulatory authorities.
Read more about our Pipeline Delivery Case Study